Bone marrow transplant is a complex procedure with significant risks. My passion is to make it so safe that anyone could have a successful transplant.
Where I see patients (2)
Selected research
-
Cyclophosphamide and thiotepa increases risk of transplant-associated thrombotic microangiopathy.
Transplantation and cellular therapy
-
Pulmonary hypertension in the intensive care unit after pediatric allogeneic hematopoietic stem cell transplant: incidence, risk factors, and outcomes.
Frontiers in oncology
-
Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation.
Nature medicine
Clinical trials
A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant
The cumulative incidence of Grade III-IV acute GVHD at Day 100 will be summarized by incidence curves. GVHD evaluations will be performed using standard criteria.37 Patients with graft rejection will be censored.
Recruiting
More about this studyJSP191 Antibody Targeting Conditioning in SCID Patients
The number of subjects experiencing dose limiting toxicities including adverse events and serious adverse events will be assessed.
Recruiting
More about this studyConditioning SCID Infants Diagnosed Early
Humoral immune reconstitution by 2 years post HCT, defined by specific antibody response to tetanus toxoid. Criteria for evaluation of humoral immune response are the following: - Donor T cell chimerism ≥50% - B cell count...
Recruiting
More about this studyEBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
Patients will be monitored for adverse events related to the infusion of EBV CTLs
Recruiting
More about this studyContact me
Translation, please
We have interpreters for Cantonese, Mandarin, Spanish, Russian, American Sign Language and more.
Request an interpreter![](/-/media/project/ucsf/ucsf-bch/images/by-your-side-moment/duck/bys_footer_duck-playful-2x.jpg?rev=1202c0da42924c018f0aa29874303fe9&hash=EA0B683476A8641ABA67D2564291622E)